With two days to go before opening arguments are set to begin in the state of New York’s multidefendant opioid lawsuit, Johnson & Johnson and New York Attorney General Letitia James on Saturday announced that the pharmaceutical company has reached a settlement, removing one of the highest-profile defendants from the suit.

The settlement involves payments of up to $263 million to the defendants, including the state of New York and Nassau and Suffolk counties, intended to help them address opioid-related issues. The money represents the share New York would have received from Johnson & Johnson’s $5 billion proposed settlement with states, cities, counties and tribal governments.